CHRISTINE LACOMB: Open Payments
NPI 1619993003 · GROVES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 10 payments from 6 companies in 2025. Trend: 2023 $232 · 2024 $90 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| PFIZER INC. | 1 | $29 |
| ABBVIE INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
Products named: TRINTELLIX, CAPLYTA, Qelbree, ELIQUIS, BOTOX, Wegovy.
Industry payments across TX — which companies pay providers there.
